353 related articles for article (PubMed ID: 29179894)
1. [Preventative and therapeutic relapse strategies after allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Beckerich F; Bulabois CE; Chevallier P; Daguindau É; Dumesnil C; Guillaume T; Huynh A; Levrat SM; Menard AL; Michallet M; Pautas C; Poiré X; Ravinet A; Yakoub-Agha I; Bazarbachi A
Bull Cancer; 2017 Dec; 104(12S):S84-S98. PubMed ID: 29179894
[TBL] [Abstract][Full Text] [Related]
2. [Second allogeneic (update). Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Yafour N; Couturier MA; Borel C; Charbonnier A; Coman T; Fayard A; Masouridi-Levrat S; Yakoub-Agha I; Roy J
Bull Cancer; 2024 Feb; 111(2S):S29-S39. PubMed ID: 37045732
[TBL] [Abstract][Full Text] [Related]
3. How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome.
Yafour N; Beckerich F; Bulabois CE; Chevallier P; Daguindau E; Dumesnil C; Guillaume T; Huynh A; Masouridi Levrat S; Menard AL; Pautas C; Poiré X; Ravinet A; Michallet M; Bazarbachi A
Curr Res Transl Med; 2017; 65(2):65-69. PubMed ID: 28687223
[TBL] [Abstract][Full Text] [Related]
4. [Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J; Baudoux E; Bay JO; Calmels B; Cras A; El Cheikh J; Guerout-Verite MA; Lacassagne MN; Lamure S; Letellier C; Menard AL; Daguindau E; Poiré X; Yakoub-Agha I; Guillaume T
Bull Cancer; 2019 Jan; 106(1S):S35-S39. PubMed ID: 30580911
[TBL] [Abstract][Full Text] [Related]
5. [Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)].
Yafour N; Couturier MA; Azarnoush S; Girault S; Hermet E; Masouridi Levrat S; Schmidt A; Michallet M; Etancelin P; Guillaume T; Malard F; Sirvent A; Yakoub-Agha I; Poiré X
Bull Cancer; 2019 Jan; 106(1S):S40-S51. PubMed ID: 30409466
[TBL] [Abstract][Full Text] [Related]
6. [Acute lymphoblastic leukemia in developing countries: Management from the transplant indication (allo/auto) until post-transplant follow-up. Guidelines from the SFGM-TC].
Yafour N; Hamzy F; Elkababri M; Yakoub-Agha I; Bekadja MA
Bull Cancer; 2023 Feb; 110(2S):S30-S38. PubMed ID: 35562231
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
9. [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
Bull Cancer; 2017 Dec; 104(12S):S106-S111. PubMed ID: 29169650
[TBL] [Abstract][Full Text] [Related]
10. Maintenance Strategies After Hematopoietic Cell Transplantation.
Culos KA; Gatwood KS; Byrne M
Pharmacotherapy; 2020 Aug; 40(8):727-740. PubMed ID: 32343426
[TBL] [Abstract][Full Text] [Related]
11. [Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
Bull Cancer; 2017 Dec; 104(12S):S112-S120. PubMed ID: 29173978
[TBL] [Abstract][Full Text] [Related]
12. [Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Conrad A; Beguin Y; Guenounou S; Le Bourgeois A; Ménard AL; Rialland F; Layal S; Mamez AC; Yakoub-Agha I; El Cheikh J
Bull Cancer; 2024 Feb; 111(2S):S40-S49. PubMed ID: 37479644
[TBL] [Abstract][Full Text] [Related]
13. [Secondary cancers following allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Loschi M; Alsuliman T; Cabrera Q; Desbrosses Y; Desmier D; Yakoub Agha I; Guillaume T
Bull Cancer; 2024 Feb; 111(2S):S22-S28. PubMed ID: 36922321
[TBL] [Abstract][Full Text] [Related]
14. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
[TBL] [Abstract][Full Text] [Related]
15. [Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Gauthier J; Chantepie S; Bouabdallah K; Jost E; Nguyen S; Gac AC; Damaj G; Duléry R; Michallet M; Delage J; Lewalle P; Morschhauser F; Salles G; Yakoub-Agha I; Cornillon J
Bull Cancer; 2017 Dec; 104(12S):S121-S130. PubMed ID: 29173973
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
17. [Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the SFGM-TC].
Beauvais D; Castilla-Llorente C; Diral E; Sirvent A; Vandewiele A; Baruchel A; Yakoub-Agha I; Yakouben K
Bull Cancer; 2023 Feb; 110(2S):S108-S115. PubMed ID: 35791974
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Nakasone H
Int J Hematol; 2023 Aug; 118(2):183-192. PubMed ID: 36807259
[TBL] [Abstract][Full Text] [Related]
19. Early detection of relapse and evaluation of treatment for mixed chimerism using fluorescence in situ hybridization following allogeneic hematopoietic cell transplant for hematological malignancies.
Tamura S; Saheki K; Takatsuka H; Wada H; Fujimori Y; Okamoto T; Takemoto Y; Hashimoto-Tamaoki T; Furuyama J; Kakishita E
Ann Hematol; 2000 Nov; 79(11):622-6. PubMed ID: 11131921
[TBL] [Abstract][Full Text] [Related]
20. [Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
Zephir H; Puyade M; Gueguen A; Michel L; Terriou L; Dive D; Laureys G; Mathey G; Labauge P; Marjanovic Z; Pugnet G; Badoglio M; Lansiaux P; Yakoub-Agha I; Béguin Y; Farge D
Bull Cancer; 2019 Jan; 106(1S):S92-S101. PubMed ID: 30527815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
